National / Science & Health Jul 22, 2020
Japan approves dexamethasone as second drug for coronavirus treatment
The inexpensive and easy-to-obtain drug is used to treat a wide range of conditions including lung disease.
Japan approves dexamethasone as second drug for coronavirus treatment
The inexpensive and easy-to-obtain drug is used to treat a wide range of conditions including lung disease.
Wave of promising study results raise hopes for coronavirus vaccines
Early data from trials of three potential COVID-19 vaccines released on Monday, including a closely watched candidate from Oxford University, increased confidence that a vaccine can train the immune system to recognize and fight the novel coronavirus without serious side effects. Whether any of these ...
Fujifilm to start another Avigan study in Kuwait following setback in Japan
The trial is to be conducted with India's Dr. Reddy's Laboratories and will involve up to 1,000 people to assess the flu drug's effectiveness against the coronavirus.
Japan in talks with Johnson & Johnson to secure COVID-19 vaccine
The company has already agreed to prioritize an allocation to the United States as part of a funding agreement, according to the firm's chief financial officer.
Coronavirus cold war flares up with claims of Russian vaccine hack
The international race for protection from the virus escalated to a new level with allegations that vaccine development has become a target of Russian cyberattacks.
Japan and Germany agree to cooperate over COVID-19 vaccine development
Abe told Merkel that his country will contribute to the development and distribution of vaccines through the WHO's ACT-Accelerator.
Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.
Promoted heavily by Prime Minister Shinzo Abe, the flu drug did not yield any statistically significant results after administered to 89 patients across Japan.
The fight over a coronavirus vaccine will get ugly
Once COVID-19 shots become available, there will be arguments about who gets them, and an even bigger battle with anti-vaxxers who refuse them.
Moderna spars with U.S. scientists over COVID-19 vaccine trials
As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc., one of the leading developers, it has been learned. The federal government is supporting Moderna’s vaccine project with nearly half a billion dollars and has ...
Takeda considers sale of OTC drug unit to focus on profitable products
Takeda Pharmaceutical Co. is considering selling its over-the-counter medicine unit for around ¥400 billion ($3.7 billion) to focus on developing cancer treatments and other advanced medical-use drugs that can generate higher profitability, a source said Monday. The envisioned sale of Takeda Consumer Healthcare Co. comes ...
How Moderna execs are cashing in during the race to develop COVID-19 vaccine
Biotech firm Moderna Inc. could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash. In the meantime, the firm’s chief executive is pocketing millions of ...